FDA halts use of Regeneron, Eli Lilly antibody drugs deemed ineffective agianst Omicron
The Food and Drug Administration on Monday halted use of monoclonal antibody treatments from Regeneron and Eli Lilly, stating they are ineffective against the Omicron COVID-19 variant. File Photo by…